BIOMAT Database Logo BIOMAT Database Logo

Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. 2002

Hideaki Kaneda, and Minoru Ohno, and Junichi Taguchi, and Masako Togo, and Hideki Hashimoto, and Ken Ogasawara, and Tadanori Aizawa, and Nobukazu Ishizaka, and Ryozo Nagai
Department of Cardiovascular Medicine, The University of Tokyo, Graduate School of Medicine, Tokyo, Japan.

OBJECTIVE Heme oxygenase (HO) is important in the defense against oxidative stress and as a factor in an antiatherogenic mechanism. Compared with long (GT)(n) repeats, short (GT)(n) repeats in the human HO-1 gene promoter were shown to have higher transcriptional activity in response to oxidative stress. There is a strong link between oxidative stress and the pathogenesis of coronary artery disease (CAD). RESULTS We screened the allelic frequencies of (GT)(n) repeats in the HO-1 gene promoter in 577 patients who underwent coronary angiography. Because the distribution of numbers of (GT)(n) repeats was bimodal, we divided the alleles into 2 subclasses: class S included shorter (<27) repeats, and class L included longer (> or =27) repeats. Multivariate logistic regression models including standard coronary risk factors revealed that the genotypes were significantly related to CAD status in hypercholesterolemic, diabetic patients or in smokers. In this study, the patients with shorter GT repeats were less likely to have CAD. CONCLUSIONS Length polymorphism in the HO-1 gene promoter is related to CAD susceptibility in Japanese people who also have coronary risk factors such as hypercholesterolemia, diabetes, and smoking. HO-1 may play an antiatherogenic role in Japanese patients with these coronary risk factors.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression

Related Publications

Hideaki Kaneda, and Minoru Ohno, and Junichi Taguchi, and Masako Togo, and Hideki Hashimoto, and Ken Ogasawara, and Tadanori Aizawa, and Nobukazu Ishizaka, and Ryozo Nagai
Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients.
July 2002, Human genetics,
Hideaki Kaneda, and Minoru Ohno, and Junichi Taguchi, and Masako Togo, and Hideki Hashimoto, and Ken Ogasawara, and Tadanori Aizawa, and Nobukazu Ishizaka, and Ryozo Nagai
Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm.
April 2002, Thrombosis research,
Hideaki Kaneda, and Minoru Ohno, and Junichi Taguchi, and Masako Togo, and Hideki Hashimoto, and Ken Ogasawara, and Tadanori Aizawa, and Nobukazu Ishizaka, and Ryozo Nagai
Heme oxygenase-1 promoter polymorphism is associated with risk of malignant mesothelioma.
June 2012, Lung,
Hideaki Kaneda, and Minoru Ohno, and Junichi Taguchi, and Masako Togo, and Hideki Hashimoto, and Ken Ogasawara, and Tadanori Aizawa, and Nobukazu Ishizaka, and Ryozo Nagai
A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma.
September 2006, International journal of cancer,
Hideaki Kaneda, and Minoru Ohno, and Junichi Taguchi, and Masako Togo, and Hideki Hashimoto, and Ken Ogasawara, and Tadanori Aizawa, and Nobukazu Ishizaka, and Ryozo Nagai
A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease.
January 2004, Thrombosis and haemostasis,
Hideaki Kaneda, and Minoru Ohno, and Junichi Taguchi, and Masako Togo, and Hideki Hashimoto, and Ken Ogasawara, and Tadanori Aizawa, and Nobukazu Ishizaka, and Ryozo Nagai
Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with progressive atherosclerosis and incident cardiovascular disease.
January 2015, Arteriosclerosis, thrombosis, and vascular biology,
Hideaki Kaneda, and Minoru Ohno, and Junichi Taguchi, and Masako Togo, and Hideki Hashimoto, and Ken Ogasawara, and Tadanori Aizawa, and Nobukazu Ishizaka, and Ryozo Nagai
Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant.
September 2005, Clinical chemistry,
Hideaki Kaneda, and Minoru Ohno, and Junichi Taguchi, and Masako Togo, and Hideki Hashimoto, and Ken Ogasawara, and Tadanori Aizawa, and Nobukazu Ishizaka, and Ryozo Nagai
Length polymorphism in heme oxygenase-1 and risk of CKD among patients with coronary artery disease.
November 2014, Journal of the American Society of Nephrology : JASN,
Hideaki Kaneda, and Minoru Ohno, and Junichi Taguchi, and Masako Togo, and Hideki Hashimoto, and Ken Ogasawara, and Tadanori Aizawa, and Nobukazu Ishizaka, and Ryozo Nagai
Microsatellite polymorphism in the heme oxygenase-1 gene promoter is not associated with alcoholic liver disease severity.
January 2014, Hepatology (Baltimore, Md.),
Hideaki Kaneda, and Minoru Ohno, and Junichi Taguchi, and Masako Togo, and Hideki Hashimoto, and Ken Ogasawara, and Tadanori Aizawa, and Nobukazu Ishizaka, and Ryozo Nagai
Heme oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion.
August 2007, Annals of surgical oncology,
Copied contents to your clipboard!